Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Bulk Anti-Human CD8 (UCHT-4) Antibody

Product Specifications

Background

Anti-CD8 may be used in studies of immunoregulation and T-lymphocyte mediated suppression, autoimmune disorders, immunodeficiency states and acute lymphoblastic leukemia and lymphoma.

CAS Number

9007-83-4

Specifications

Anti-CD8 In Vivo Antibody - Low Endotoxin (UCHT-4) recognizes Human CD8. Anti-Human CD8 recognizes a T-cell glycoprotein cell surface complex (Mr 32 kDa) which defines the cytotoxic/suppressor population of mature T-lymphocytes. The CD8 complex interacts with class I MHC molecules resulting in increased adhesion between CD8+ T-lymphocytes and their target cells. Binding of the CD8 antigen to Class I MHC molecules enhances T-cell activation. The cytoplasmic portion of the CD8 antigen is associated with a protein tyrosine kinase (p56lck).

Host

Mouse

Species Reactivity

Human

Target

CD8

Isotype

IgG2a

Clone

UCHT-4

Applications

Flow Cytometry, Western Blot, Immunoprecipitation, Functional Assays, IHC, Immunofluorescence, ELISA

Purification Method

This monoclonal antibody was purified using Protein A

Concentration

1.0 - 5.0 mg/mL

Endotoxin

<1.0 EU/mg as determined by the LAL method

Purity

>95% by SDS-PAGE and HPLC

Buffer

ICH3001-100mL ICH3002-100mL ICH3003-100mL

Shipping Conditions

Blue ice

Storage Conditions

Anti-CD8 In Vivo Antibody - Low Endotoxin (UCHT-4) is stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.

Formulation

0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added.

Antigen Distribution

The CD8 antigen is expressed on approximately 19-48% of normal human peripheral blood lymphocytes and > 90% of normal thymocytes. It is also present on a subset of NK cells. Subjects infected with HIV have been shown to exhibit increased levels of CD8+ lymphocytes with a continual decrease in CD4+ lymphocytes.

Aggregation

Aggregation level ≤ 5%

Applications Notes

Each investigator should determine their own optimal working dilution for specific applications.

Isotype Control

https://www.ichor.bio/product/Mouse-IgG2a-In-Vivo-Isotype-Control-Low-Endotoxin-C1.18.4-ICH2245

More Discoveries

Explore Other Products

Browse additional items from our catalog

Lentiviral human KMO shRNA (UAS) - Lentiviral human KMO shRNA (UAS, GFP) plasmid
GTR15108946 1 Vial

Lentiviral human KMO shRNA (UAS) - Lentiviral human KMO shRNA (UAS, GFP) plasmid

Sign In for Pricing
View Details
Pre-S1 (12-32)
5-01787 4x 1 mg

Pre-S1 (12-32)

Sign In for Pricing
View Details
Slc2a10 3'UTR Luciferase Stable Cell Line
TU220579 1.0 mL

Slc2a10 3'UTR Luciferase Stable Cell Line

Sign In for Pricing
View Details
Synovial Microvascular Endothelial Cells, Human (T-25 flask) discontinued
353395-T25 T-25 flask

Synovial Microvascular Endothelial Cells, Human (T-25 flask) discontinued

Sign In for Pricing
View Details
PRAK (MAPKAPK5) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1A7]
TA804234BM 100 µL

PRAK (MAPKAPK5) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1A7]

Sign In for Pricing
View Details
SET07 Antibody (C-term) Blocking Peptide
MBS9218724-01 0.5 mg

SET07 Antibody (C-term) Blocking Peptide

Sign In for Pricing
View Details